申请人:SmithKline Corporation
公开号:US03931232A1
公开(公告)日:1976-01-06
The compounds of this invention are 3-alkyl xanthenes having pharmacological activity such as central nervous system activity. Preferred compounds of this invention are 3-(1,2-dimethylheptyl)-5,6,7,8-tetrahydro-1-hydroxy-9-methylxanthene, 3-(1,2-dimethylheptyl)-1-hydroxy-6,9-dimethylxanthene and 3-(1,2-dimethylheptyl)-1-hydroxy-9-methylxanthene.
本发明的化合物是具有药理活性的3-烷基黄色素,如中枢神经系统活性。本发明的优选化合物是3-(1,2-二甲基庚基)-5,6,7,8-四氢-1-羟基-9-甲基黄色素,3-(1,2-二甲基庚基)-1-羟基-6,9-二甲基黄色素和3-(1,2-二甲基庚基)-1-羟基-9-甲基黄色素。